Krystal Biotech Inc (KRYS)
170.85
-5.54
(-3.14%)
USD |
NASDAQ |
Nov 04, 16:00
171.06
+0.21
(+0.12%)
After-Hours: 20:00
Krystal Biotech Total Liabilities (Quarterly): 78.76M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 78.76M |
March 31, 2024 | 54.05M |
December 31, 2023 | 39.71M |
September 30, 2023 | 34.40M |
June 30, 2023 | 30.91M |
March 31, 2023 | 42.28M |
December 31, 2022 | 36.22M |
September 30, 2022 | 35.61M |
June 30, 2022 | 42.14M |
March 31, 2022 | 68.32M |
December 31, 2021 | 32.72M |
September 30, 2021 | 42.86M |
June 30, 2021 | 25.02M |
March 31, 2021 | 12.37M |
December 31, 2020 | 18.76M |
Date | Value |
---|---|
September 30, 2020 | 9.731M |
June 30, 2020 | 8.449M |
March 31, 2020 | 6.762M |
December 31, 2019 | 6.109M |
September 30, 2019 | 6.586M |
June 30, 2019 | 6.866M |
March 31, 2019 | 6.218M |
December 31, 2018 | 2.89M |
September 30, 2018 | 2.161M |
June 30, 2018 | 0.759M |
March 31, 2018 | 0.452M |
December 31, 2017 | 0.64M |
September 30, 2017 | 2.475M |
June 30, 2017 | 0.584M |
December 31, 2016 | 1.893M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.109M
Minimum
Dec 2019
78.76M
Maximum
Jun 2024
32.90M
Average
34.40M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
Bioventus Inc | 603.11M |
ADMA Biologics Inc | 188.13M |
Axsome Therapeutics Inc | 445.37M |
Amicus Therapeutics Inc | 616.96M |
Sarepta Therapeutics Inc | 2.347B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 917.66M |
Shareholders Equity (Quarterly) | 838.89M |
Current Ratio | 9.503 |